Zai Lab (ZLAB) News Today $30.38 -1.14 (-3.62%) Closing price 04:00 PM EasternExtended Trading$30.00 -0.38 (-1.25%) As of 07:03 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period All You Need to Know About Zai Lab Limited (ZLAB) Rating Upgrade to BuyApril 15 at 3:57 PM | msn.comFIL Ltd Decreases Stock Position in Zai Lab Limited (NASDAQ:ZLAB)FIL Ltd trimmed its position in shares of Zai Lab Limited (NASDAQ:ZLAB - Free Report) by 11.3% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 111,713 shares of the company's stock after selling 14,228 shares during the quartApril 15 at 4:16 AM | marketbeat.comZai Lab Limited (NASDAQ:ZLAB) Shares Purchased by Fmr LLCFmr LLC raised its position in Zai Lab Limited (NASDAQ:ZLAB - Free Report) by 749.1% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 5,475,505 shares of the company's stock after purchasing an additional 4,830,646 shares during the period. Fmr LLC ownedApril 15 at 3:58 AM | marketbeat.comRussell Investments Group Ltd. Sells 25,938 Shares of Zai Lab Limited (NASDAQ:ZLAB)Russell Investments Group Ltd. lessened its position in shares of Zai Lab Limited (NASDAQ:ZLAB - Free Report) by 10.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 231,694 shares of the company's stock after selling 25,938 shares duApril 15 at 3:49 AM | marketbeat.comZai Lab (NASDAQ:ZLAB) Shares Gap Up - Still a Buy?Zai Lab (NASDAQ:ZLAB) Shares Gap Up - Should You Buy?April 13 at 10:54 AM | marketbeat.comDymon Asia Capital Singapore PTE. LTD. Makes New $524,000 Investment in Zai Lab Limited (NASDAQ:ZLAB)Dymon Asia Capital Singapore PTE. LTD. purchased a new position in Zai Lab Limited (NASDAQ:ZLAB - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 20,000 shares of the company's stock, valued at aApril 13 at 7:27 AM | marketbeat.comOrion Portfolio Solutions LLC Buys New Shares in Zai Lab Limited (NASDAQ:ZLAB)Orion Portfolio Solutions LLC purchased a new position in shares of Zai Lab Limited (NASDAQ:ZLAB - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 11,956 shares of the company's stoApril 12 at 4:09 AM | marketbeat.comZai Lab (NASDAQ:ZLAB) Shares Down 7.1% on Insider SellingZai Lab (NASDAQ:ZLAB) Shares Down 7.1% After Insider SellingApril 11, 2025 | marketbeat.comZai Lab (NASDAQ:ZLAB) Shares Down 7.1% Following Insider SellingApril 11, 2025 | americanbankingnews.comZai Lab Limited (ZLAB): Among Stocks Insiders Sold in April After Trump’s Tariff RolloutApril 10, 2025 | msn.comADAR1 Capital Management LLC Has $27.39 Million Stock Holdings in Zai Lab Limited (NASDAQ:ZLAB)ADAR1 Capital Management LLC boosted its stake in Zai Lab Limited (NASDAQ:ZLAB - Free Report) by 96.4% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,045,837 shares of the company's stock after acquiring an additional 513,383 shares durApril 9, 2025 | marketbeat.comZai Lab Limited (NASDAQ:ZLAB) CFO Yajing Chen Sells 924 SharesApril 9, 2025 | insidertrades.comYajing Chen Sells 924 Shares of Zai Lab Limited (NASDAQ:ZLAB) StockZai Lab Limited (NASDAQ:ZLAB - Get Free Report) CFO Yajing Chen sold 924 shares of the company's stock in a transaction dated Friday, April 4th. The stock was sold at an average price of $33.11, for a total value of $30,593.64. Following the transaction, the chief financial officer now directly owns 27,047 shares of the company's stock, valued at approximately $895,526.17. This represents a 3.30 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link.April 9, 2025 | marketbeat.comZai Lab Limited (NASDAQ:ZLAB) Insider Frazor Titus Edmondson III Sells 1,874 SharesZai Lab Limited (NASDAQ:ZLAB - Get Free Report) insider Frazor Titus Edmondson III sold 1,874 shares of the stock in a transaction dated Friday, April 4th. The stock was sold at an average price of $33.11, for a total transaction of $62,048.14. Following the completion of the transaction, the insider now directly owns 30,375 shares of the company's stock, valued at $1,005,716.25. This trade represents a 5.81 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.April 9, 2025 | marketbeat.comZai Lab Limited (NASDAQ:ZLAB) CEO Sells $97,508.95 in StockZai Lab Limited (NASDAQ:ZLAB - Get Free Report) CEO Ying Du sold 2,945 shares of the firm's stock in a transaction that occurred on Friday, April 4th. The stock was sold at an average price of $33.11, for a total transaction of $97,508.95. Following the sale, the chief executive officer now owns 479,851 shares of the company's stock, valued at $15,887,866.61. This trade represents a 0.61 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.April 9, 2025 | marketbeat.comZai Lab management to meet with Cantor FitzgeraldApril 8, 2025 | markets.businessinsider.comZai Lab (ZLAB) Gets a Buy from ScotiabankApril 8, 2025 | markets.businessinsider.comSchroder Investment Management Group Decreases Stock Holdings in Zai Lab Limited (NASDAQ:ZLAB)Schroder Investment Management Group cut its stake in Zai Lab Limited (NASDAQ:ZLAB - Free Report) by 61.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 91,504 shares of the company's stocApril 8, 2025 | marketbeat.comFrazor Titus Edmondson III Sells 4,369 Shares of Zai Lab Limited (NASDAQ:ZLAB) StockZai Lab Limited (NASDAQ:ZLAB - Get Free Report) insider Frazor Titus Edmondson III sold 4,369 shares of the company's stock in a transaction that occurred on Wednesday, April 2nd. The stock was sold at an average price of $35.89, for a total value of $156,803.41. Following the completion of the sale, the insider now owns 27,217 shares of the company's stock, valued at $976,818.13. This trade represents a 13.83 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.April 5, 2025 | marketbeat.comYajing Chen Sells 5,280 Shares of Zai Lab Limited (NASDAQ:ZLAB) StockZai Lab Limited (NASDAQ:ZLAB - Get Free Report) CFO Yajing Chen sold 5,280 shares of Zai Lab stock in a transaction dated Wednesday, April 2nd. The stock was sold at an average price of $35.89, for a total value of $189,499.20. Following the completion of the transaction, the chief financial officer now owns 25,471 shares of the company's stock, valued at $914,154.19. This trade represents a 17.17 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.April 5, 2025 | marketbeat.comZai Lab Limited (NASDAQ:ZLAB) CEO Sells $208,449.12 in StockZai Lab Limited (NASDAQ:ZLAB - Get Free Report) CEO Ying Du sold 5,808 shares of the firm's stock in a transaction on Wednesday, April 2nd. The stock was sold at an average price of $35.89, for a total value of $208,449.12. Following the completion of the transaction, the chief executive officer now owns 476,046 shares in the company, valued at $17,085,290.94. The trade was a 1.21 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink.April 5, 2025 | marketbeat.comRaymond James Financial Inc. Purchases Shares of 39,420 Zai Lab Limited (NASDAQ:ZLAB)Raymond James Financial Inc. purchased a new stake in Zai Lab Limited (NASDAQ:ZLAB - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 39,420 shares of the company's stock, valued atApril 5, 2025 | marketbeat.comZai Lab (NASDAQ:ZLAB) Trading Down 3.5% - Here's What HappenedZai Lab (NASDAQ:ZLAB) Shares Down 3.5% - Here's WhyApril 4, 2025 | marketbeat.comFrazor Titus Edmondson III Sells 4,369 Shares of Zai Lab Limited (NASDAQ:ZLAB) StockApril 4, 2025 | insidertrades.comZai Lab Limited (NASDAQ:ZLAB) Position Lessened by Wellington Management Group LLPWellington Management Group LLP reduced its stake in shares of Zai Lab Limited (NASDAQ:ZLAB - Free Report) by 21.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,657,735 shares of the company's stockApril 4, 2025 | marketbeat.comZai Lab (NASDAQ:ZLAB) Shares Up 2.9% - What's Next?Zai Lab (NASDAQ:ZLAB) Shares Up 2.9% - Here's What HappenedApril 3, 2025 | marketbeat.comClearbridge Investments LLC Boosts Stock Position in Zai Lab Limited (NASDAQ:ZLAB)Clearbridge Investments LLC grew its position in Zai Lab Limited (NASDAQ:ZLAB - Free Report) by 113.3% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,862,842 shares of the company's stock after purchasing an additional 989,664 shares during thApril 2, 2025 | marketbeat.comZai Lab (NASDAQ:ZLAB) Hits New 1-Year High - What's Next?Zai Lab (NASDAQ:ZLAB) Reaches New 1-Year High - Should You Buy?March 29, 2025 | marketbeat.comZai Lab (NASDAQ:ZLAB) Shares Gap Up - Here's What HappenedZai Lab (NASDAQ:ZLAB) Shares Gap Up - Here's WhyMarch 28, 2025 | marketbeat.comCantor Fitzgerald Reaffirms Overweight Rating for Zai Lab (NASDAQ:ZLAB)Cantor Fitzgerald reissued an "overweight" rating on shares of Zai Lab in a research report on Thursday.March 28, 2025 | marketbeat.comFox Run Management L.L.C. Purchases New Holdings in Zai Lab Limited (NASDAQ:ZLAB)Fox Run Management L.L.C. acquired a new position in shares of Zai Lab Limited (NASDAQ:ZLAB - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 13,946 shares of the company'sMarch 27, 2025 | marketbeat.comZai Lab to Present New Data from Internally Developed, Next-Generation Oncology Candidates at AACR 2025 Annual MeetingMarch 26, 2025 | finance.yahoo.comZai Lab (NASDAQ:ZLAB) Shares Gap Down - Time to Sell?Zai Lab (NASDAQ:ZLAB) Shares Gap Down - What's Next?March 22, 2025 | marketbeat.comZai Lab Limited (NASDAQ:ZLAB) Shares Purchased by DCF Advisers LLCDCF Advisers LLC increased its holdings in Zai Lab Limited (NASDAQ:ZLAB - Free Report) by 53.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 64,750 shares of the company's stock after buying an additionalMarch 22, 2025 | marketbeat.comZai Lab: Innovative Pharma Set For Strong Year Of Business (And Share Price) GrowthMarch 21, 2025 | seekingalpha.comZai Lab Limited (NASDAQ:ZLAB) Insider Rafael Amado Sells 3,000 SharesZai Lab Limited (NASDAQ:ZLAB - Get Free Report) insider Rafael Amado sold 3,000 shares of the business's stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $38.41, for a total value of $115,230.00. Following the completion of the sale, the insider now directly owns 30,834 shares of the company's stock, valued at approximately $1,184,333.94. This represents a 8.87 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.March 20, 2025 | marketbeat.comZai Lab: Still Attractive Despite Higher Costs And Added Trade War RisksMarch 20, 2025 | seekingalpha.comRafael Amado Sells 3,000 Shares of Zai Lab Limited (NASDAQ:ZLAB) StockMarch 20, 2025 | insidertrades.comPrivium Fund Management B.V. Has $4.85 Million Position in Zai Lab Limited (NASDAQ:ZLAB)Privium Fund Management B.V. decreased its holdings in shares of Zai Lab Limited (NASDAQ:ZLAB - Free Report) by 14.2% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 185,062 shares of the company's stockMarch 20, 2025 | marketbeat.comZurcher Kantonalbank Zurich Cantonalbank Invests $1.67 Million in Zai Lab Limited (NASDAQ:ZLAB)Zurcher Kantonalbank Zurich Cantonalbank purchased a new position in shares of Zai Lab Limited (NASDAQ:ZLAB - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 63,909 shares of the company's stock, valued at approximatelMarch 18, 2025 | marketbeat.comZai Lab (NASDAQ:ZLAB) Sets New 1-Year High After Analyst UpgradeZai Lab (NASDAQ:ZLAB) Reaches New 52-Week High Following Analyst UpgradeMarch 15, 2025 | marketbeat.comZai Lab (NASDAQ:ZLAB) Price Target Raised to $51.00 at JPMorgan Chase & Co.JPMorgan Chase & Co. boosted their price objective on shares of Zai Lab from $44.00 to $51.00 and gave the company an "overweight" rating in a research report on Thursday.March 14, 2025 | marketbeat.comIs Zai Lab Limited (ZLAB) the Best Performing Growth Stock in 2025?March 14, 2025 | insidermonkey.comConnor Clark & Lunn Investment Management Ltd. Boosts Stake in Zai Lab Limited (NASDAQ:ZLAB)Connor Clark & Lunn Investment Management Ltd. increased its position in Zai Lab Limited (NASDAQ:ZLAB - Free Report) by 39.3% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 841,735 shares of the company's stock after purchasing an additional 237,582 shares duriMarch 14, 2025 | marketbeat.comAnalysts Offer Insights on Healthcare Companies: Zai Lab (ZLAB), Perspective Therapeutics (CATX) and Edesa Biotech (EDSA)March 13, 2025 | markets.businessinsider.comZai Lab price target raised to $51 from $44 at JPMorganMarch 13, 2025 | markets.businessinsider.comZai Lab Limited Announces Equity Incentive GrantsMarch 13, 2025 | tipranks.comZai Lab announces acceptance of BLA for TIVDAK in cervical cancerMarch 12, 2025 | markets.businessinsider.comZai Lab Announces Acceptance of Biologics License Application for TIVDAK for the Treatment of Patients with Recurrent or Metastatic Cervical CancerMarch 12, 2025 | businesswire.comZai Lab (ZLAB) Initiated with a Buy at ScotiabankMarch 10, 2025 | markets.businessinsider.com Remove Ads Get Zai Lab News Delivered to You Automatically Sign up to receive the latest news and ratings for ZLAB and its competitors with MarketBeat's FREE daily newsletter. Email Address ZLAB Media Mentions By Week ZLAB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ZLAB News Sentiment▼0.810.80▲Average Medical News Sentiment ZLAB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ZLAB Articles This Week▼165▲ZLAB Articles Average Week Remove Ads Get Zai Lab News Delivered to You Automatically Sign up to receive the latest news and ratings for ZLAB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Genmab A/S News Dr. Reddy's Laboratories News Moderna News Ascendis Pharma A/S News Qiagen News Viatris News Roivant Sciences News Lantheus News Revolution Medicines News BridgeBio Pharma News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ZLAB) was last updated on 4/15/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zai Lab Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Zai Lab With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ZLAB Stock Free ZLAB Stock Alerts